NCT00753272 Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older Status COMPLETED Phase PHASE3
NCT00752869 Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement Status COMPLETED Phase PHASE4
NCT00752167 Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes Status COMPLETED Phase N/A
NCT00752089 Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model Status COMPLETED Phase PHASE2
NCT00751686 Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece Status COMPLETED Phase N/A
NCT00751348 Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 Status COMPLETED Phase PHASE3
NCT00750893 Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants Status COMPLETED Phase N/A
NCT00750360 Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age. Status COMPLETED Phase PHASE4
NCT00750256 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00749411 Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD Status COMPLETED Phase PHASE2
NCT00748410 Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT00746811 Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia Status COMPLETED Phase PHASE4
NCT00746174 Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone Status COMPLETED Phase PHASE4
NCT00743860 A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848 Status COMPLETED Phase PHASE1
NCT00743405 Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00743067 A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00742885 Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine Status COMPLETED Phase PHASE2